On Invalid Date, Astrazeneca (NASDAQ: AZN) reported Q3 2022 earnings per share (EPS) of $0.53, up 196.36% year over year. Total Astrazeneca earnings for the quarter were $1.64 billion. In the same quarter last year, Astrazeneca's earnings per share (EPS) was -$0.55.
As of Q1 2023, Astrazeneca's earnings has grown -13.95% year over year. This is 53.44 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 39.48%. Astrazeneca's earnings in the past year totalled $2.04 billion.
On Invalid Date, Astrazeneca (NASDAQ: AZN) reported Q3 2022 revenue of $10.98 billion up 11.31% year over year. In the same quarter last year, Astrazeneca's revenue was $9.87 billion.
What was AZN's revenue growth in the past year?
As of Q1 2023, Astrazeneca's revenue has grown 37.6% year over year. This is 25.26 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 12.34%. Astrazeneca's revenue in the past year totalled $45.15 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.